Emostasi e Trombosi SI di. PO49 | PROPHYLACTIC ANTICOAGULATION DECISIONS IN HIGH-RISK PATIENTS RECEIVING CANCER-DIRECTED THERAPY: ANALYSIS OF THE VERMONT METHOD: J. Barker1, K. Libby1, C. Holmes2, K. Martin2 | 1University of Vermont Health System; 2Department of Medicine, University of Vermont, Burlington, VT, USA. Bleeding Thromb Vasc Biol [Internet]. 2026 Apr. 16 [cited 2026 May 5];5(s1). Available from: https://www.btvb.org/btvb/article/view/541